---

Background: Urogenital atrophy is a common problem after menopause and quality of life in post-menopauseis seriously affected by the symptoms associated with vaginal atrophy. The aim of this study was to compare the effectiveness of the vaginal suppository of hyaluronic acid and vitamin E in atrophic vaginitis treatment. Materials and Methods: This randomized double-blind clinical trialwas carried out in Ahvaz (Iran) from August to December 2010. Forty postmenopausal women with symptoms of vaginal atrophy were randomly allocatedto two groups to take vaginal suppositories of either 5 mg hyaluronic acid sodium salt (n=20) or 1 mg vitamin E (n=20) for 8 weeks. The symptoms of vaginal atrophy were evaluated by a self-assessed 4-point scaleand the composite score was determined asnone, mild, moderate, and severe in four periods. Results: The results showed that the symptoms were relieved significantly in both groups (P<0.001).The relief of symptoms was significantly superior in the hyaluronic acid group compared with the vitamin E group (P<0.05). Conclusion: Although both hyaluronic acid and vitamin E relieved the vaginal symptoms, improvements were greater in the hyaluronic acid group. Therefore,hyaluronic acid vaginal suppository is suggested for women with vaginal atrophy who do not want to or cannot take local estrogen treatment.

---

Background: Menopause being the most critical period, the unfavorable changes in anthropometric and metabolic parameters associated with CVD risk. Metabolic syndrome is the key factor for cardiovascular disease and has become major problem in many countries. With the high prevalence of metabolic syndrome, especially in women after menopause, this study was performed to investigate the relationship between the menopausal age and metabolic syndrome in non-obese postmenopausal women.

Materials and Methods: This cross sectional study on 140 healthy non-obese postmenopausal women who had a BMI less than30 Kg/m2, at 2009 in Ahvaz the data were contained demographic information, menopausal age, BMI, values of HDL-C, FBS, TG serum after 12 houres fasting, blood pressure and waist circumference. We used the Pearson correlation and multiple regression analysis by SPSS15 software.

Results: Menopausal age with FBS (p=0.04) was negatively significant. But there was not any correlation between menopausal age with other Components of metabolic syndrome. [triglycerides (p=0.28), systolic blood pressure (p=0.80) diastolic blood pressure (p=0.48), waist circumference (p=0.08), HDL-C(p=0.65)].

Conclusion: Late menopause has favourable effect on fasting glucose.

---

Background: Menopause is a critical period in the women life which is associated with different neurophysiological and cognitive changes. This study aimed to determine the relationship between menopausal symptoms with metabolic syndrome in postmenopausal women.

Materials and Methods: This descriptive - analytical study was conducted on 165 postmenopausal women referred to health centers in Ahvaz. Data collection tools were standardized questionnaire menopausal rating symptoms (MRS), questionnaire to record demographic information and the results of experiments and measurements (blood pressure, Waist circumference). The data were analyzed by Pearson correlation coefficients, Mann-Whitny in by SPSS version 19.

Results: The results showed that the overall mean of MRS in this study was 11.85±5.4. The mean of metabolic syndrome was 36±4.8 percent and we found significant association between blood pressure (p=0.04), blood sugar (p=0.02),HDL-C(p=0.02) and urogenital symptoms. But there werent significant relationship between other metabolic syndrome components and other menopausal symptoms (somatic and psychological Dimensions).

Conclusion: The relationship was observed between metabolic syndrome and urogenital symptoms, therefore, as a preventative health strategy women with urogenital complaints should examin for metabolic syndrome.